IL71001A - Mouse-mouse hybridoma cell line atcc hb8209 and its monoclonal antibody to erythropoietin - Google Patents

Mouse-mouse hybridoma cell line atcc hb8209 and its monoclonal antibody to erythropoietin

Info

Publication number
IL71001A
IL71001A IL71001A IL7100184A IL71001A IL 71001 A IL71001 A IL 71001A IL 71001 A IL71001 A IL 71001A IL 7100184 A IL7100184 A IL 7100184A IL 71001 A IL71001 A IL 71001A
Authority
IL
Israel
Prior art keywords
mouse
cell line
erythropoieten
monoclonal antibody
erythropoietin
Prior art date
Application number
IL71001A
Other languages
English (en)
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23841115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL71001(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Priority to IL8922984A priority Critical patent/IL89229A/xx
Priority to IL89229A priority patent/IL89229A0/xx
Publication of IL71001A publication Critical patent/IL71001A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746—Erythropoetin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL71001A 1983-02-04 1984-02-17 Mouse-mouse hybridoma cell line atcc hb8209 and its monoclonal antibody to erythropoietin IL71001A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL8922984A IL89229A (en) 1983-02-04 1984-02-17 Quantitative detection and isolation of erythropoietin
IL89229A IL89229A0 (en) 1983-02-04 1989-02-09 Mouse-mouse hybridoma cell line attc hb8209 and its monoclonal antibody to erythropoietin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/463,724 US4558006A (en) 1983-02-04 1983-02-04 A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin

Publications (1)

Publication Number Publication Date
IL71001A true IL71001A (en) 1990-06-10

Family

ID=23841115

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71001A IL71001A (en) 1983-02-04 1984-02-17 Mouse-mouse hybridoma cell line atcc hb8209 and its monoclonal antibody to erythropoietin

Country Status (8)

Country Link
US (1) US4558006A (de)
EP (1) EP0116446B1 (de)
JP (1) JPS60500558A (de)
AT (1) ATE55780T1 (de)
CA (1) CA1210345A (de)
DE (1) DE3483008D1 (de)
IL (1) IL71001A (de)
WO (1) WO1984003152A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
CN1063969C (zh) * 1984-11-30 2001-04-04 柯瑞英-艾格公司 含多肽的药物组合物的制备方法
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
JPH02265498A (ja) * 1988-11-16 1990-10-30 Shionogi & Co Ltd ｒｅｇタンパク質を認識するモノクローナル抗体
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
SE9004047L (sv) * 1990-12-19 1992-06-20 Francisco Batista Metod foer immobilisering av tiolfoereningar via aktivering av polymerer, aktiverade polymerer, och produkter erhaallna med metoden
US5625035A (en) * 1992-06-05 1997-04-29 The Regents, University Of California Erythropoietin binding protein from mammalian serum
US6048704A (en) 1996-03-07 2000-04-11 The Trustees Of Columbia University Purified and recombinant antigenic protein associated with abdominal aortic aneurysm (AAA) disease, and diagnostic and therapeutic use thereof
JP2002512039A (ja) 1998-04-22 2002-04-23 コーネル リサーチ ファンデーション インク． イヌエリスロポエチン遺伝子および組換えタンパク質
US6696411B1 (en) * 1998-04-22 2004-02-24 Cornell Research Foundation, Inc. Canine erythropoietin gene and recombinant protein
RU2145610C1 (ru) * 1998-12-09 2000-02-20 Общество с ограниченной ответственностью "Протеиновый контур" Способ очистки рекомбинантного эритропоэтина человека
RU2151184C1 (ru) * 1998-12-09 2000-06-20 Общество с ограниченной ответственностью "Протеиновый контур" Штаммы культивируемых гибридом мышей - продуценты моноклональных антител к человеческому эритропоэтину и антитела, ими продуцируемые
CN102552263A (zh) 2001-12-06 2012-07-11 法布罗根股份有限公司 提高内源性红细胞生成素(epo)的方法
KR100473172B1 (ko) * 2002-11-27 2005-03-10 씨제이 주식회사 인간 에리스로포이에틴과 변형 에리스로포이에틴을 모두인식하는 모노클로날 항체 및 그를 생산하는 융합세포주
CA2521273A1 (en) * 2003-04-02 2004-10-21 Epimmune Inc. Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
EP1736481A1 (de) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietinvarianten
AU2015249144B2 (en) * 2005-08-05 2017-06-29 Araim Pharmaceuticals, Inc. Tissue protective peptides and uses thereof
HUE026444T2 (en) 2005-08-05 2016-05-30 Araim Pharmaceuticals Inc Tissue protection peptides and their use
US20080260746A1 (en) * 2005-11-24 2008-10-23 Laboratoires Serono Sa Erythropoietin Polypeptides and Uses Thereof
WO2009094172A2 (en) 2008-01-22 2009-07-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
RU2451071C1 (ru) * 2010-12-10 2012-05-20 Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к рекомбинантному эритропоэтину человека (варианты)
CN103608346B (zh) 2011-02-02 2016-06-15 菲布罗根有限公司 作为缺氧诱导因子(hif)羟化酶抑制剂的萘啶衍生物
EP2872487B1 (de) 2012-07-16 2017-04-26 Fibrogen, Inc. Verfahren zur herstellung von isochinolinverbindungen
KR20210130849A (ko) 2012-07-16 2021-11-01 피브로겐, 인크. 프롤릴 하이드록실라제 억제제 [(4-하이드록시-1-메틸-7-페녹시-아이소퀴놀린-3-카보닐)-아미노]-아세트산의 결정형
RU2717038C1 (ru) * 2019-01-29 2020-03-17 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Штамм клеток cho-se-9/4 - продуцент химерного антитела против эритропоэтина человека и химерное антитело, продуцируемое данным штаммом

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US465624A (en) * 1891-12-22 Hydrocarbon-burner
US3033753A (en) * 1959-08-31 1962-05-08 Wilfrid F White Erythropoietic factor purification
US4423147A (en) * 1980-04-11 1983-12-27 Secher David S Monoclonal antibody to interferon-α
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
IT1185503B (it) * 1984-01-11 1987-11-12 Univ New York Cloni di odna di eritropietina umana

Also Published As

Publication number Publication date
WO1984003152A1 (en) 1984-08-16
EP0116446B1 (de) 1990-08-22
EP0116446A3 (en) 1986-05-14
EP0116446A2 (de) 1984-08-22
CA1210345A (en) 1986-08-26
ATE55780T1 (de) 1990-09-15
US4558006A (en) 1985-12-10
JPS60500558A (ja) 1985-04-25
DE3483008D1 (de) 1990-09-27

Similar Documents

Publication Publication Date Title
IL71001A (en) Mouse-mouse hybridoma cell line atcc hb8209 and its monoclonal antibody to erythropoietin
US4699880A (en) Method of producing monoclonal anti-idiotype antibody
DE3278203D1 (en) Monoclonal antibodies specific for the human transferrin receptor glycoprotein
Cordon-Cardo et al. Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract
NZ211989A (en) Monoclonal anticytomegalovirus antibodies and diagnostic system
US5084380A (en) Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5013645A (en) Immunological methods and materials for detection of tumor associated antigens
David et al. The hybridoma-an immunochemical laser.
ATE62273T1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
IL80718A (en) Murine derived hybridoma cell lines producing monoclonal antibodies to human pluripotent granulocyte colony stimulating factor
EP0401370B1 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren
Furuta et al. Production of monoclonal antibody against a glucosyltransferase of Streptococcus mutans 6715
ATE87941T1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
McEwan et al. Monoclonal Antibody Against Human Tyrosine and Reactive With Melanotic and Amelanotic Melanoma Cells
MY103022A (en) Monoclonal antibodies recognizing l-thyroxine
US5094942A (en) Detection of antibodies binding carboxypeptidase in serum of cancer patients
EP0315447A3 (de) Verfahren zur immunologischen Bestimmung von humanem Protein S sowie Reagens und Kit dafür
GB2199833A (en) Preparation of monoclonal antibodies
Bosslet et al. Monoclonal murine antibodies with specificity for tissue culture lines of human squamous-cell carcinoma of the lung
US4891312A (en) Monoclonal antibody specific for human colon fibroblast-derived t-PA
Choi Serological precipitation method for studying biosynthesis and secretion of immunoglobulins by human peripheral blood lymphocytes
ES8609725A1 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
Bütikofer et al. ‘Crossed immunoblotting’: Identification of proteins after crossed immunoelectrophoresis and electrotransfer to nitrocellulose membranes
Telakowski-Hopkins et al. Isolation and characterization of monoclonal antibodies against rat liver epoxide hydrolase
Hoag et al. Optimal conditions for isolating human placental alkaline phosphatase by immunosorption

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired